文献速递甲状腺与颈部外科围术期管理与 ERAS

甲状旁腺切除术治疗无症状原发性甲状旁腺功能亢进症:纳入骨折风险降低的修正成本效果分析

Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction.
PubMed 文献 · Surgery · 2016-11-09

该研究采用马尔可夫模型,比较甲状旁腺切除术与指南推荐的医学观察对60岁女性轻度无症状原发性甲状旁腺功能亢进症的成本效果,并纳入术后骨折风险降低。结果显示甲状旁腺切除术为优势策略,增量成本节省1721美元,增量效果0.185质量调整生命年,蒙特卡洛模拟显示1000例中995例具成本效果。

要点

  • 甲状旁腺切除术相比观察可节省成本并增加质量调整生命年。
  • 术后骨折相对风险降低≥14%时,手术仍为优势策略。
  • 骨折成本≥7600美元或喉返神经损伤概率<12.5%时,手术仍占优。

核心结论

  • 在纳入骨折风险降低后,对于轻度无症状原发性甲状旁腺功能亢进症,甲状旁腺切除术相比观察为优势策略。

研究设计与样本

  • 马尔可夫转换状态模型,比较甲状旁腺切除术与指南推荐的医学观察,针对60岁女性轻度无症状原发性甲状旁腺功能亢进症患者。
  • 成本采用已发表的Medicare报销数据估算,治疗策略结局包括骨折风险通过文献综述确定。
  • 使用质量调整因子对治疗结局加权,成本效果阈值设为100000美元/质量调整生命年。
  • 进行敏感性分析和蒙特卡洛模拟以检验不确定性对模型的影响。

主要发现

  • 甲状旁腺切除术为优势策略(成本更低且更有效),增量成本节省1721美元,增量效果0.185质量调整生命年。
  • 当术后骨折相对风险降低≥14%、骨折成本≥7600美元或喉返神经损伤概率<12.5%时,甲状旁腺切除术仍为优势策略。
  • 蒙特卡洛模拟显示,在1000例假设患者中,甲状旁腺切除术在995例中具有成本效果。

关键数值与推荐

  • 成本效果阈值:100000美元/质量调整生命年。
  • 甲状旁腺切除术优势策略的敏感性条件:骨折相对风险降低≥14%、骨折成本≥7600美元、喉返神经损伤概率<12.5%。
  • 蒙特卡洛模拟:995/1000例假设患者中甲状旁腺切除术具成本效果。

临床怎么用

  • 对于60岁女性轻度无症状原发性甲状旁腺功能亢进症患者,考虑骨折风险降低时,甲状旁腺切除术可能比观察更具成本效果。
  • 临床决策可参考术后骨折风险降低程度、骨折成本和喉返神经损伤概率等参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent data demonstrate decreased fracture risk after operation for asymptomatic primary hyperparathyroidism. We performed a revised cost-effectiveness analysis comparing parathyroidectomy versus observation while incorporating fracture risk reduction. METHODS: A Markov transition-state model was created comparing parathyroidectomy and guideline-based medical observation for a 60-year-old female patient with mild asymptomatic primary hyperparathyroidism. Costs were estimated using published Medicare reimbursement data. Treatment strategy outcomes, including risk of fracture, were identified by literature review. Quality adjustment factors were used to weight treatment outcomes. A threshold of $100,000/quality-adjusted life year was used to determine cost-effectiveness. Sensitivity analyses and Monte Carlo simulation were performed to examine the effect of uncertainty on the model. RESULTS: Parathyroidectomy was the dominant strategy (less costly and more effective) with an incremental cost savings of $1,721 and an incremental effectiveness of 0.185 quality-adjusted life years. Parathyroidectomy remained dominant when the relative risk reduction of fracture after operation was ≥14%, the cost of fracture was ≥$7,600, or the probability of recurrent laryngeal nerve injury was <12.5%. Monte Carlo simulation showed parathyroidectomy was cost-effective in 995/1,000 hypothetical patients. CONCLUSION: When fracture risk reduction is considered, parathyroidectomy for mild asymptomatic primary hyperparathyroidism is the dominant strategy when compared to observation.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Zanocco KA, Wu JX, Yeh MW, et al. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery. 2016. PMID: 27836213. doi:10.1016/j.surg.2016.06.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。